TAP-Block in Abdominal Aortic Surgery

Phase 4

Completed

• Conditions: Aortic Aneurysm, Abdominal
• Interventions: Drug: Placebo; Drug: Ropivacaine

• Registration Number: NCT03657979
• Lead Sponsor: Centre Hospitalier Universitaire Dijon

Brief Summary

The primary outcome of this study was the evaluation of the efficacy of TAP block on pain intensity following open abdominal aortic surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09-05
• Primary Completion: 2012-08-29
• Study Completion: 2012-08-29
• Study First Submitted: 2018-06-29
• Status Verified: 2018-09
• Study First Submitted QC: 2018-09-03
• Last Update Submitted: 2018-09-03
• Study First Posted: 2018-09-05
• Last Update Posted: 2018-09-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Open abdominal aortic surgery (aneurysm or aortobifemoral bypass)
• Person who has given his written consent

Exclusion Criteria

• Emergency surgery
• Patient with infection
• Use of opioids in the long term
• History of chronic pain
• Higher functions incompatible with the functioning of the PCA
• Patients under guardianship

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
TAP-block with placebo	Placebo	Conventional PCA morphine treatment with TAP-block with placebo
Ropivacaine	Ropivacaine	Conventional PCA morphine +TAP-block ropivacaine 0.2%

Primary Outcome Measures

Name	Time	Method
Evaluation of morphine consumption at 24 postoperative hours	24 hours	Morphine consumption (Patient Controlled Analgesia) statement during the first 24 postoperative hours

Secondary Outcome Measures

Name	Time	Method
Evaluation of Visual Analogue Scale scores at 24 postoperative hours	24 hours	Visual Analogue Scale scores statement during the first 24 postoperative hours (minimum pain 0 - maximum pain 10)

Trial Locations

Locations (1)

Cardiovascular and thoracic surgery unit, CHU Dijon; 🇫🇷 Dijon Cedex, France